Back
Arcus Biosciences, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
19
RCUS
Arcus Biosciences, Inc.
Last Price:
$22.22
Seasonality Move:
-9.85%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiArcus Biosciences, Inc. Stock Forecast
-
Over the next 52 weeks, Arcus Biosciences, Inc. has on average historically risen by 33.5% based on the past 7 years of stock performance.
-
Arcus Biosciences, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is Arcus Biosciences, Inc. Stock Undervalued?The current Arcus Biosciences, Inc. [RCUS] share price is $22.28. The Score for RCUS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
RCUS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Arcus Biosciences, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Arcus Biosciences, Inc. has on average historically risen by 33.5% based on the past 7 years of stock performance.
Arcus Biosciences, Inc. Stock Rating
Sell
19
Arcus Biosciences, Inc. (RCUS)
is a Sell
Is Arcus Biosciences, Inc. overpriced?
-
Arcus Biosciences, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
Arcus Biosciences, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcusbio.com
52-Week Data
52-Week High:
26.40
52-Week Low:
6.50
Prediction Charts
Market Cap:
2.8B
Price in USD:
22.28
Volume:
2M
Beta:
1.00
Technical Analysis
SMA50:
20.61
SMA100:
15.90
SMA200:
12.34
52-Wk Change:
38.56%
Stock Predictions
-
Is Arcus Biosciences, Inc. stock public?Yes, Arcus Biosciences, Inc. is a publicly traded company.
-
What is the Arcus Biosciences, Inc. stock quote today?The Arcus Biosciences, Inc. stock price is 22.28 USD today.
-
How to buy Arcus Biosciences, Inc. stock online?You can buy Arcus Biosciences, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-28 | 25.81 | 26.10 | 26.32 | 25.62 |
| Dec-1 | 25.56 | 26.10 | 26.27 | 25.12 |
| Dec-2 | 25.76 | 25.43 | 26.35 | 24.77 |
| Dec-3 | 25.62 | 25.63 | 26.40 | 25.33 |
| Dec-4 | 25.31 | 25.26 | 25.87 | 24.32 |
| Dec-5 | 25.44 | 25.45 | 25.80 | 24.67 |
| Dec-8 | 25.72 | 25.80 | 26.25 | 25.43 |
| Dec-9 | 25.78 | 25.07 | 26.40 | 25.01 |
| Dec-10 | 25.04 | 25.40 | 26.02 | 24.75 |
| Dec-11 | 25.71 | 25.14 | 26.10 | 25.10 |
| Dec-12 | 21.15 | 21.53 | 24.00 | 20.35 |
| Dec-15 | 21.51 | 21.91 | 22.01 | 20.81 |
| Dec-16 | 21.62 | 22.20 | 22.41 | 21.27 |
| Dec-17 | 22.35 | 22.28 | 22.49 | 21.87 |
Arcus Biosciences, Inc. Earnings
Arcus Biosciences, Inc. Earnings Report: Per Share Arcus Biosciences, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcus Biosciences, Inc. Forecast Revenue Growth
Arcus Biosciences, Inc. Stock Analysis: Historical quarterly revenues per share for Arcus Biosciences, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.37 per share.
* Arcus Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.